Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VR Exposure Therapy vs Sertraline in Social Anxiety Disorder
NCT07192367Phase 4Recruiting
- Start
- Nov 2024
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 4, open-label trial (2 arms). Primary endpoint: Liebowitz Social Anxiety Scale at 12 weeks. Started Nov 2024; status: recruiting.
Beyond the preview
Go deeper on NCT07192367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07192367.